my ApoB moved and I cannot work out whether 503A is why
Something I noticed reading old threads that I have not seen said out loud.
The advice on 503A in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers with the same confidence.
I have listed what I think the current consensus is below. Correct me — that is the point of posting it.
best — the order this archive was captured in
Are we talking 503A or 503B?
API transparency is the question that separates good compounders from sketchy ones
Mechanistically the bit that matters is shortage list. It explains most of the early profile and a decent chunk of the outcome.
API source questions are on-topic and compounders dodging them is newsworthy
What is the actual shortage list status right now?
The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.
Strongly agree. API source transparency matters.
Are we talking 503A or 503B?
Asked 24 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.
Yeah, 503A and 503B are different regulatory animals.
the the UK situation is different from the US, different regulations
the shortage list is temporary, it ends and compounding becomes illegal again
shortage list status is 503B, check the actual list
Yeah, 503A and 503B are different regulatory animals.
Which state? Rules vary.
state board rules differ, say which state
Disagree but this is the good kind of wrong — it is specific enough to be checked.
This is correct. The shortage list does expire and the rules change.
no pharmacy referral codes, naming is fine, recruiting is not
Tracking number removed. It identifies both ends of a shipment.
regulatory claims need a citation to the actual rule, not interpretation
shortage list status is 503B, check the actual list
Disagree on that part. 95.1% and 98.3% on the same vial is normal.
You have restated the marketing copy. What is the actual substance here.
API transparency is the question that separates good compounders from sketchy ones
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
shortage list status is 503A, check the actual list
The telehealth + compounding combo cost API source plus 23% markup. Not cheap but covered by insurance depending on state.
Yeah, 503A and 503B are different regulatory animals.
Yeah, 503A and 503B are different regulatory animals.
Disagree on that part. 99.2% and 95.1% on the same vial is normal.
- 1shortage list status is 503B, check the actual list13 comments in this branch · started by u/ruben_cabrera
- 2Strongly agree. API source transparency matters.6 comments in this branch · started by u/zaid_grimaldi